EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cell-based therapies for malignant glioma

Rachael Mooney iD, Eslam E Abd El-Fattah, Gary Ngai iD, Jacqueline Lara, Mohamed Hammad, Karen S Aboody

Stem Cells Translational Medicine · 16.10.2026 · 15 (11)

DOI: 10.1093/stcltm/szag084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 21.10.2026. Verfasst von Rachael Mooney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Biology and Regenerative Medicine, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA 91010,…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Cell- and Tissue-Based Therapy. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ben & Catherine Ivy Foundation, Rosalinde and Arthur Gilbert Foundation, the Alvarez Charitable Foundation, City of Hope, California Instistute of Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite innovative progress, cellular therapies have not produced durable, population-level survival gains in glioblastoma. Across 3 major modalities, engineered effectors such as chimeric antigen receptor T cell (CAR-T) and natural killer (NK) cells, immune-education platforms such as dendritic and whole-cell vaccines, and carrier cells delivering oncolytic or drug payloads, trials have shown measurable bioactivity, but durability has varied. This likely reflects systemic barriers, including therapy-induced lymphopenia, myeloid dominance, and T-cell sequestration, as well as local barriers such as antigen heterogeneity and immune suppression. To understand why some studies nevertheless showed more favorable efficacy signals, we reviewed clinical outcomes across these modalities and identified 4 recurring design features that appeared repeatedly among studies reporting more favorable survival signals: treatment in the minimal residual disease setting, a T-helper type 1 supportive context, broadened antigenic coverage, and effective immune hand-off from the initiating therapy to endogenous or adoptively transferred effectors. Across heterogeneous early-phase studies, greater feature alignment sometimes co-occurred with more favorable signals, although this retrospective pattern is descriptive and does not establish association or causality. These observations may help guide future biomarker-informed strategies and provide a practical framework for organizing multimodal trials aimed at converting transient bioactivity into more durable, polyclonal control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsCell- and Tissue-Based TherapyHumansAnimalsImmunotherapy, AdoptiveKiller Cells, Natural

Stichwörter der Autor:innen

CAR-T cellsNK cellscell therapyclinical trialsglioblastomagliomaimmunotherapymyeloid immune cellsoncolytic virotherapystem cells

Autor:innen und Institutionen

  • Department of Stem Cell Biology and Regenerative Medicine, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA 91010, United States.
  • Department of Medical Oncology, University Hospitals and Case Western Reserve University, Cleveland, OH 44106, United States.

ORCID-Profile: Rachael Mooney, Gary Ngai

Förderung

  • Ben & Catherine Ivy Foundation
  • Rosalinde and Arthur Gilbert Foundation, the Alvarez Charitable Foundation, City of Hope, California Instistute of Regenerative Medicine

Zitieren

APA

Mooney, R., Abd El-Fattah, E. E., Ngai, G., Lara, J., Hammad, M., & Aboody, K. S. (2026). Cell-based therapies for malignant glioma. Stem Cells Translational Medicine, 15(11). https://doi.org/10.1093/stcltm/szag084

Vancouver

Mooney R, Abd El-Fattah EE, Ngai G, Lara J, Hammad M, Aboody KS. Cell-based therapies for malignant glioma. Stem Cells Translational Medicine. 2026;15(11). doi:10.1093/stcltm/szag084

BibTeX
@article{Mooney2026,
  author = {Mooney, Rachael and Abd El-Fattah, Eslam E and Ngai, Gary and Lara, Jacqueline and Hammad, Mohamed and Aboody, Karen S},
  title = {Cell-based therapies for malignant glioma},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1093/stcltm/szag084}
}
Kostenlos starten →